| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |